| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $17,778,517 ) (Continued on the next page) |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21HD108634 | Machine learning Approaches to Radiological Dating of Infant Clavicle Fractures" | 000 | 2 | NIH | 10/27/2023 | $238,950 |
| | 2024 | 2024 | Children's Hospital Corporation, The | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | 90YE0303 | California Tribal Evaluation of Child Care and Development Fund Policies and Initiatives Implementation | 01 | 1 | ACF | 11/22/2023 | $300,000 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K01DA057374 | Mobile health applications in adolescent marijuana use: assessing the interplay among sleep, pain and inhibitory control | 000 | 2 | NIH | 11/16/2023 | $179,189 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21CA277460 | Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer | 000 | 2 | NIH | 11/13/2023 | $186,183 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R37AI091476 | Therapeutic use of an enhanced form of CD4-Ig | 000 | 16 | NIH | 11/21/2023 | $795,889 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21AI173596 | Improving mRNA vaccines with extracellular vesicle-associated immunogens | 000 | 3 | NIH | 11/1/2023 | $199,125 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01CA233671 | Role of METTL3 and the m6A Epitranscriptome in cancer | 000 | 5 | NIH | 11/6/2023 | $578,243 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI143771 | Global post-transcriptional regulators in P. aeruginosa | 000 | 5 | NIH | 11/27/2023 | $521,213 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01CA255216 | Non-invasive imaging of the anti-tumor immune response | 000 | 4 | NIH | 11/3/2023 | $528,877 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI119918 | Mast cell regulation of Th2 induction and tolerance breakdown in food allergy | 000 | 9 | NIH | 11/21/2023 | $538,820 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01CA013202 | Structure and Assembly of Viruses | 000 | 51 | NIH | 11/14/2023 | $378,338 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AR080079 | Epigenetic dysregulation of muscle differentiation in Kabuki syndrome | 000 | 3 | NIH | 11/15/2023 | $477,031 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99HL171947 | Novel role of Foxc2 in regulating metabolic disease | 000 | 1 | NIH | 11/20/2023 | $125,658 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152133 | Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria | 000 | 4 | NIH | 11/6/2023 | $517,939 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS124879 | Developmentally Programmed Remodeling of Apical ECM | 000 | 3 | NIH | 11/7/2023 | $393,522 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS120986 | Predicting ASD and Other Developmental Outcomes in the First Year of Life Using EEG in a Diverse Community-Based Sample | 000 | 3 | NIH | 12/1/2023 | $613,843 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL167450 | Desmosomes in cardiomyocyte homeostasis and disease | 000 | 2 | NIH | 11/29/2023 | $729,538 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EB032708 | Fetal MRI: robust self-driving brain acquisition and body movement quantification | 000 | 3 | NIH | 10/26/2023 | $623,069 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL163937 | CMYA5 regulation of cardiac dyad structure and function | 000 | 2 | NIH | 11/28/2023 | $548,110 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK124328 | Role of TAZ in metabolic regulation in both normal and insulin resistant states | 000 | 4 | NIH | 11/16/2023 | $406,311 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL162642 | Balancing epithelial cell resistance and resilience to respiratory viral infections | 000 | 2 | NIH | 12/4/2023 | $748,218 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL162367 | The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | 000 | 3 | NIH | 11/16/2023 | $663,643 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL161092 | Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes | 000 | 3 | NIH | 11/27/2023 | $615,137 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY035684 | Kinase regulators of retinal ganglion cell survival and axon regeneration | 000 | 1 | NIH | 11/21/2023 | $652,092 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01MH111647 | How do neurons in the brain decide to refine their synaptic connections in vivo? | 000 | 7 | NIH | 11/16/2023 | $782,621 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DC008853 | Functional development of hair cells and neurons in the inner ear | 000 | 14 | NIH | 11/15/2023 | $484,792 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL156362 | The role of signaling adaptor protein epsin in atherosclerosis | 000 | 4 | NIH | 11/10/2023 | $707,330 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL155632 | Transcription Factor 4 Maintain Endothelial identity to Oppose Heart Failure | 000 | 3 | NIH | 11/7/2023 | $451,532 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K12HD052896 | Child Health Research Career Development Award (CHRCDA) Program (K12) | 002 | 17 | NIH | 11/30/2023 | $444,599 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K00MH133546 | Role of glycosylation in environmental and genetic schizophrenia risk | 000 | 3 | NIH | 12/5/2023 | $86,065 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32MD017452 | Sexual Minority Mental Health During the COVID-19 Pandemic: An Intersectional, Social Epidemiologic Investigation | 000 | 2 | NIH | 11/22/2023 | $73,580 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32HL172637 | Endothelial and mural cell interaction in capillary malformation | 000 | 1 | NIH | 11/20/2023 | $71,792 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T32HL066987 | Transfusion Biology and Cellular Therapies | 003 | 22 | NIH | 12/1/2023 | $257,696 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32DK130267 | The role of TTC7A in apical lumen formation and polarized trafficking in the intestinal epithelium | 000 | 2 | NIH | 11/2/2023 | $78,972 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21EY035902 | Elucidating synaptic motifs in the visual thalamus | 000 | 1 | NIH | 11/17/2023 | $221,250 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | UH3CA243120 | Natural Language Processing Platform for Cancer Surveillance | 000 | 5 | NIH | 12/1/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T32HS000063 | Training in Child Health Services Research and Implementation Science | 001 | 30 | AHRQ | 10/31/2023 | $48,049 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI155796 | Development, Optimization and Preclinical Modeling of Hematopoietic Stem Cell Gene Editing for the Treatment of RAG1 Immunodeficiency | 001 | 4 | NIH | 11/22/2023 | $442,500 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R00MH128892 | Identifying prefrontal signatures of successful and dysfunctional attention | 000 | 2 | NIH | 10/12/2023 | $2,222 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI148235 | Inhibiting sequential biosynthetic steps of a fungal-specific organelle | 000 | 4 | NIH | 11/17/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99DK134760 | Clonal dynamics of the blood stem cell niche | 000 | 1 | NIH | 10/31/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99AR083482 | Elucidating the neuroimmune mechanisms underlying pain and inflammation in autoimmune arthritis | 000 | 1 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99NS126233 | Circuit Dynamics of Structuring Episodic Memories in Humans | 000 | 2 | NIH | 12/5/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R03AG070766 | Mechanisms underlying glutamate dyshomeostasis in Alzheimer's disease | 000 | 2 | NIH | 11/21/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HS026246 | Patient Safety Event Surveillance Using Machine Learning and Free Text Clinical Notes | 001 | 5 | AHRQ | 11/14/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS131098 | eCD4-mediated control of SIV infection in the brain | 000 | 1 | NIH | 12/1/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HD096901 | SHIPSS: Stress Hydrocortisone In Pediatric Septic Shock | 000 | 4 | NIH | 10/18/2023 | $0 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK115217 | Type III interferon Control of Mucosal Immunity | 001 | 5 | NIH | 11/28/2023 | $77,186 |
| | 2024 | 2023 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY034135 | The trigeminal nociceptive-pain pathway in pediatric mTBI: peripheral and central contributions to photophobia | 000 | 1 | NIH | 11/8/2023 | $0 |
|
